CBE for Randox MD

CBE for Randox MD

THE MANAGING Director of Crumlin company Randox Laboratories, Dr Peter Fitzgerald said that he was honoured to be awarded a CBE for Services to Business in Northern Ireland in the New Years Honours list.

Dr FitzGerald, who founded Randox Laboratories in 1982 said: "I feel extremely honoured to receive this award. It is a reflection of the dedication of all Randox employees and the life saving products we develop. We are committed to improving healthcare worldwide and we will continue to work hard and further our growth to maintain this achievement."

Hide Ad
Hide Ad

Dr Fitzgerald founded Randox almost 30 years ago with, he said, a desire to improve healthcare worldwide. Randox is now ranked as one of the leading clinical diagnostic companies in the world, with established offices in Europe, USA and the Far East.

Randox employs 850 people, selling products to over 130 countries worldwide and re-invests over 7 million into Research and Development each year.

Their products utilise cutting edge technology and are of the highest quality set to revolutionise healthcare through continuously improving diagnostic solutions.

"Randox has continued to grow and recruit throughout the economic crisis, providing exciting career opportunities for individuals from all backgrounds," said Dr Fitzgerald. "It provides opportunities within science based disciplines as well as sales and marketing, engineering, logistics, human resources, finance, manufacturing, information technology and many more. The presentation of this CBE is testament to the dedication of the entire Randox workforce and is recognition of the life saving work the company performs."

Hide Ad
Hide Ad

Although Randox has achieved so much since 1982, Dr FitzGerald still has no intention of slowing down. Randox has many new revolutionary products planned for release in 2011 that will make patient testing faster, simpler and more accurate.

Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. It has extensive product portfolio which offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control.

It aims to 'revolutionise healthcare through continuously improving diagnostic solutions' and continue to achieve this by re-investment in Research and Development. They say their innovative approach to diagnostics allows them to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results.